Выпуск №2 за 2010 год
The main aim of the work described
in this article is efficiency and safety
estimation of Rezorba (zoledronic
acid) in prostate cancer patients with
bone metastasies (MTS). This drug
suppresses...
Выпуск №4 за 2011 год
In recent time interest for new methods
of malignant tumors is growing,
one of the most promising is immune
therapy. The main reason of such interest
is caused by the fact that nearly
one third of...
Выпуск №4 за 2011 год
One of the biggest problems in the diagnosis
of prostate cancer (PCa), which
distinguishes it from many other solid
tumors, is the difficulty of visualization
of the tumor process by using modern...
Выпуск №1 за 2011 год
At present time the challenge of prostate cancer early detection becomes more and more vital due to prostate cancer (PCa) is one of the most common malignant tumors in males. Development and...
Выпуск №3 за 2010 год
Not only clinical efficiency but costeffectiveness
is to be considered in a
choice of treatment option, particularly
in oncologic patients. Oncologic
patients treatment needs large...
Выпуск №3 за 2010 год
Most frequent prostate cancer radiation
therapy complications are radiation,
prostatitis cystitis and proctitis,
with dysuria of different degree of
manifestating. It can be also...